HOME >> MEDICINE >> NEWS
A giant step toward tiny functional nanowires

EVANSTON, Ill. --- Carving a telephone pole is easy if you have the right tools, say a power saw and some large chisels. And with some much tinier tools you could even carve a design into a paper clip if you wanted to. But shrink your sights down to the nanoscale, to a nanowire that is 1,000 times smaller than the diameter of a paper clip, and you find there are no physical tools to do the job properly.

So a team of Northwestern University scientists turned to chemistry and developed a new method that can routinely and cheaply produce nanowires with gaps as small as five nanometers wide -- a feat that is unattainable using conventional lithographic techniques. The results will be published in the July 1 issue of the journal Science.

Carved gaps are essential to a nanowire's function, and controlling those gaps would allow scientists and engineers to design with precision devices ranging from tiny integrated circuits to gene chips and protein arrays for diagnostics and drug discovery.

"With miniaturization happening across so many fields, our existing tools -- our chisels of a sort -- can't control the shapes and spacing of these small structures," said Chad A. Mirkin, director of Northwestern's Institute for Nanotechnology, who led the research team. "Our method allows us to selectively introduce gaps into the wires. These gaps can be filled with molecules, making them components for building small electronic and photonic devices or chemical and biological sensors."

The development of sophisticated nanoelectronics, said Mirkin, depends on the ability to fabricate and functionalize electrode gaps less than 20 nanometers wide for precise electrical measurements on nanomaterials and even individual molecules. While conventional techniques can't make gaps much smaller than 20 nanometers wide, Mirkin's method, called on-wire lithography, or OWL, has been able to produce gaps as small as 2.5 nanometers wide.

Mirkin and his team
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
30-Jun-2005


Page: 1 2

Related medicine news :

1. Brief, high-dose steroid treatment offers extended relief to giant cell arteritis patients
2. Progress toward an antitumor vaccine
3. Free public talk on epilepsy research and progress towards better treatment
4. New study in Sleep finds a high level of negativity towards judicial sleepiness
5. Kenya moves toward national food and nutrition policy
6. A sweet step toward new cancer therapies
7. Comprehensive reforms to move toward patient-centered care released by ACP
8. Pioneers in field of functional genomics work toward gene therapy for vision defects
9. Breastfeeding overcomes a genetic tendency toward ear infections, scientists discover
10. Fosrenol data show evidence of trends towards improved bone formation in CKD stage 5 patients
11. Rutgers College of Nursing professor to examine Latinas attitudes towards exercise

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: giant step toward tiny functional nanowires

(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: